Expected To Support Operations Into 2026 Conference Webcast Scheduled for Today at 8:30AM ET AUSTIN, Texas, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical ...
The law firm of Kessler Topaz Meltzer & Check, LLP ( informs investors that a securities class action lawsuit has been filed against Cassava Sciences, Inc. ("Cassava") (NASDAQ: SAVA) on behalf of ...
Sava gets regulatory approval from the South African Reserve Bank (SARB) to launch a digital banking platform focused solely ...
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 ...
The South African Reserve Bank (SARB) has granted regulatory approval for a collaboration between Access Bank South Africa and Sava, to introduce an African digital banking platform that enables SMEs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback